277 related articles for article (PubMed ID: 28419935)
1. Identification of a host cell protein impurity in therapeutic protein, P1.
Ahluwalia D; Dhillon H; Slaney T; Song H; Boux H; Mehta S; Zhang L; Valdez A; Krishnamurthy G
J Pharm Biomed Anal; 2017 Jul; 141():32-38. PubMed ID: 28419935
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
[TBL] [Abstract][Full Text] [Related]
3. Comparison of platform host cell protein ELISA to process-specific host cell protein ELISA.
Gunawan F; Nishihara J; Liu P; Sandoval W; Vanderlaan M; Zhang H; Krawitz D
Biotechnol Bioeng; 2018 Feb; 115(2):382-389. PubMed ID: 28986978
[TBL] [Abstract][Full Text] [Related]
4. ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry.
Henry SM; Sutlief E; Salas-Solano O; Valliere-Douglass J
MAbs; 2017 Oct; 9(7):1065-1075. PubMed ID: 28708446
[TBL] [Abstract][Full Text] [Related]
5. More similar than different: Host cell protein production using three null CHO cell lines.
Yuk IH; Nishihara J; Walker D; Huang E; Gunawan F; Subramanian J; Pynn AF; Yu XC; Zhu-Shimoni J; Vanderlaan M; Krawitz DC
Biotechnol Bioeng; 2015 Oct; 112(10):2068-83. PubMed ID: 25894672
[TBL] [Abstract][Full Text] [Related]
6. A novel approach to evaluate ELISA antibody coverage of host cell proteins-combining ELISA-based immunocapture and mass spectrometry.
Pilely K; Nielsen SB; Draborg A; Henriksen ML; Hansen SWK; Skriver L; Mørtz E; Lund RR
Biotechnol Prog; 2020 Jul; 36(4):e2983. PubMed ID: 32087048
[TBL] [Abstract][Full Text] [Related]
7. Toward unbiased identification and comparative quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development.
Huang Y; Molden R; Hu M; Qiu H; Li N
J Pharm Biomed Anal; 2021 Jun; 200():114069. PubMed ID: 33901758
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Host Cell Proteins (HCPs) in CHO Cell Bioprocesses.
Hogwood CEM; Chiverton LM; Mark Smales C
Methods Mol Biol; 2017; 1603():243-250. PubMed ID: 28493135
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics.
Jawa V; Joubert MK; Zhang Q; Deshpande M; Hapuarachchi S; Hall MP; Flynn GC
AAPS J; 2016 Nov; 18(6):1439-1452. PubMed ID: 27450229
[TBL] [Abstract][Full Text] [Related]
10. Improved host cell protein analysis in monoclonal antibody products through ProteoMiner.
Chen IH; Xiao H; Li N
Anal Biochem; 2020 Dec; 610():113972. PubMed ID: 32979367
[TBL] [Abstract][Full Text] [Related]
11. Toward the complete characterization of host cell proteins in biotherapeutics via affinity depletions, LC-MS/MS, and multivariate analysis.
Madsen JA; Farutin V; Carbeau T; Wudyka S; Yin Y; Smith S; Anderson J; Capila I
MAbs; 2015; 7(6):1128-37. PubMed ID: 26291024
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of host cell proteins in biopharmaceuticals from chinese hamster ovarian and vero cell lines using capillary electrophoresis western blots.
Pearson C; Wang Y; Alkurdi E; Zhang Y; Yin K; Rustandi RR; Loughney JW
J Pharm Biomed Anal; 2023 Sep; 233():115420. PubMed ID: 37207489
[TBL] [Abstract][Full Text] [Related]
13. Experience with host cell protein impurities in biopharmaceuticals.
Vanderlaan M; Zhu-Shimoni J; Lin S; Gunawan F; Waerner T; Van Cott KE
Biotechnol Prog; 2018 Jul; 34(4):828-837. PubMed ID: 29693803
[TBL] [Abstract][Full Text] [Related]
14. Improved Host Cell Protein Analysis in Monoclonal Antibody Products through Molecular Weight Cutoff Enrichment.
Chen IH; Xiao H; Daly T; Li N
Anal Chem; 2020 Mar; 92(5):3751-3757. PubMed ID: 31999105
[TBL] [Abstract][Full Text] [Related]
15. Questioning coverage values determined by 2D western blots: A critical study on the characterization of anti-HCP ELISA reagents.
Seisenberger C; Graf T; Haindl M; Wegele H; Wiedmann M; Wohlrab S
Biotechnol Bioeng; 2021 Mar; 118(3):1116-1126. PubMed ID: 33241851
[TBL] [Abstract][Full Text] [Related]
16. Trace levels of the CHO host cell protease cathepsin D caused particle formation in a monoclonal antibody product.
Bee JS; Tie L; Johnson D; Dimitrova MN; Jusino KC; Afdahl CD
Biotechnol Prog; 2015; 31(5):1360-9. PubMed ID: 26259961
[TBL] [Abstract][Full Text] [Related]
17. In-house CHO HCPs platform: A promising approach for HCPs ELISA monitoring.
Giordano E; Liori B; Cecchini I; Verani R; Leone L
Eur J Pharm Sci; 2024 Jan; 192():106656. PubMed ID: 38029932
[TBL] [Abstract][Full Text] [Related]
18. A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in Antibodies.
Huang L; Wang N; Mitchell CE; Brownlee T; Maple SR; De Felippis MR
Anal Chem; 2017 May; 89(10):5436-5444. PubMed ID: 28414239
[TBL] [Abstract][Full Text] [Related]
19. Quantitative host cell protein analysis using two dimensional data independent LC-MS(E).
Farrell A; Mittermayr S; Morrissey B; Mc Loughlin N; Navas Iglesias N; Marison IW; Bones J
Anal Chem; 2015 Sep; 87(18):9186-93. PubMed ID: 26280711
[TBL] [Abstract][Full Text] [Related]
20. Host cell protein testing by ELISAs and the use of orthogonal methods.
Zhu-Shimoni J; Yu C; Nishihara J; Wong RM; Gunawan F; Lin M; Krawitz D; Liu P; Sandoval W; Vanderlaan M
Biotechnol Bioeng; 2014 Dec; 111(12):2367-79. PubMed ID: 24995961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
